ATP4B and type 1 diabetes mellitus: Based on a cut-off corresponding to the mean plus 3 standard deviations of the control subjects, 7 of the 50 T1D samples (14%) were seropositive above the cut-off for anti-ATP4B antibodies and showed much higher titers with 96% specificity.